Article
The Role and Therapeutic Value of Syndecan-1 in Cancer Metastasis and Drug Resistance
18 Jan 2022
Abstract excerpt
Metastasis and relapse are major causes of cancer-related fatalities. The elucidation of relevant pathomechanisms and adoption of appropriate countermeasures are thus crucial for the development of clinical strategies that inhibit malignancy progression as well as metastasis. An integral component of the extracellular matrix, the type 1 transmembrane glycoprotein syndecan-1 (SDC-1) binds cytokines and growth...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
